Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis

Hepatology

Volumn 59, Issue 5, 2014, Pages 1954-1963

  Boonstra, Kirsten ^a   Culver, Emma L ^b   de Buy Wenniger, Lucas Maillette ^a   van Heerde, Marianne J ^d   van Erpecum, Karel J ^e   Poen, Alexander C ^f   van Nieuwkerk, Karin M J ^g   Spanier, B W Marcel ^h   Witteman, Ben J M ⁱ   Tuynman, Hans A R E ^j   van Geloven, Nan ^a   van Buuren, Henk ^d   Chapman, Roger W ^b   Barnes, Eleanor ^b,c   Beuers, Ulrich ^a   Ponsioen, Cyriel Y ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f ISALA HOSPITAL   (Netherlands)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h RIJNSTATE HOSPITAL   (Netherlands)

ⁱ GELDERSE VALLEI HOSPITAL   (Netherlands)

^j Location Alkmaar   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CHOLANGITIS; CHOLANGITIS, SCLEROSING; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 84899473581     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26977     Document Type: Article

References (35)

1. Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 2012;56:1181-1188.
2. Krones E, Graziadei I, Trauner M, Fickert P. Evolving concepts in primary sclerosing cholangitis. Liver Int 2012;32:352-369.
3. Boonstra K, Weersma R, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, et al. Population-based epidemiology, malignancy risk and outcome of primary sclerosing cholangitis. Hepatology 2013;58:2045-2055.
4. Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 2009;50:158-164.
5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51:237-267.
6. Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum 2012;64:3061-3067.
7. Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008;134:706-715.
8. Kamisawa T, Takuma K, Egawa N, Tsuruta K, Sasaki T. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol 2010;7:401-409.
9. Culver E, Bateman A. IgG4-related disease: can non-classical histopathological features or the examination of clinically uninvolved tissues be helpful in the diagnosis? J Clin Pathol 2012;65:963-969.
10. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012;366:539-551.
11. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012;25:1181-1192.
12. Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009;39:469-477.
13. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-738.
14. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol 2007;42(Suppl 1):39-41.
15. Alderlieste YA, van den Elzen BD, Rauws EA, Beuers U. Immunoglobulin G4-associated cholangitis: one variant of immunoglobulin G4-related systemic disease. Digestion 2009;79:220-228.
16. Maillette de Buy Wenniger L, Rauws EA, Beuers U. What an endoscopist should know about immunoglobulin-G4-associated disease of the pancreas and biliary tree. Endoscopy 2012;44:66-73.
17. Nishino T, Oyama H, Hashimoto E, Toki F, Oi I, Kobayashi M, Shiratori K. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol 2007;42:550-559.
18. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ; American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010;51:660-678.
19. Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006;101:2070-2075.
20. Zhang L, Lewis JT, Abraham SC, Smyrk TC, Leung S, Chari ST, et al. IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis. Am J Surg Pathol 2010;34:88-94.
21. Björnsson E, Chari S, Silveira M, Gossard A, Takahashi N, Smyrk T, Lindor K. Primary sclerosing cholangitis associated with elevated immunoglobulinG4: clinical characteristics and response to therapy. Am J Ther 2011;18:198-205.
22. Vosskuhl K, Negm AA, Framke T, Weismüller T, Manns MP, Wedemeyer H, et al. Measurement of IgG4 in bile: a new approach for the diagnosis of IgG4-associated cholangiopathy. Endoscopy 2012;44:48-52.
23. Parhizkar B, Mohammad Alizadeh AH, Asadzadeh Aghdaee H, Malekpour H, Entezari AH. Primary sclerosing cholangitis associated with elevated immunoglobulin-g4: a preliminary study. ISRN Gastroenterol 2012;2012:32574.
24. Maillette de Buy Wenniger L, Doorenspleet M, Klarenbeek P, Verheij J, Baas F, Elferink RP, et al. IgG4+ clones identified by next-generation sequencing dominate the b-cell receptor repertoire in IgG4-associated cholangitis. Hepatology 2013;57:2390-2398.
25. Leisenring W, Alonzo T, Pepe MS. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics 2000;56:345-351.
26. R development core team. R: a language and environment for statistical computing [Internet]. Vienna: 2011. Available at: www.r-project.org/. Accessed December 2012.
27. Ohara H, Nakazawa T, Kawa S, Kamisawa T, Shimosegawa T, Uchida K, et al. Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis-a japanese cohort. J Gastroenterol Hepatol 2013;28:1247-1251.
28. Oseini AM, Chaiteerakij R, Shire AM, Ghazale A, Kaiya J, Moser CD, et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 2011;54:940-948.
29. Zen Y, Nakanuma Y, Portmann B. Immunoglobulin G4-related sclerosing cholangitis: pathologic features and histologic mimics. Semin Diagn Pathol 2012;29:205-211.
30. Howlett DC, Drinkwater KJ, Lawrence D, Barter S, Nicholson T. Findings of the UK national audit evaluating image-guided or image-assisted liver biopsy. Part II. Minor and major complications and procedure-related mortality. Radiology 2013;266:226-235.
31. Lee Y-M, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995;332:924-933.
32. Riggione O, Stokes R, Thompson R. Predominance of IgG3 subclass in primary biliary cirrhosis. Br Med J (Clin Res Ed) 1983;286:1015-1016.
33. Bogdanos D-P, Baum H, Okamoto M, Montalto P, Sharma UC, Rigopoulou EI, et al. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology 2005;42:458-465.
34. Rigopoulou EI, Davies ET, Bogdanos DP, Liaskos C, Mytilinaiou M, Koukoulis GK, et al. Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int 2007;27:1226-1231.
35. Schroeder HW, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol 2010;125(2 Suppl 2):S41-S52.